Gelonghui November 11th | Chenguang Biotech Group (300138.SZ) stated on the investor interaction platform that the company's sugar substitute products are mainly stevia sugar, with a current production capacity of 2000 tons/year. The products have a production cost advantage and yield is in a leading position in the industry.
晨光生物(300138.SZ)：代糖产品主要为甜菊糖，目前产能为2000吨/年
Chenguang Biotech Group (300138.SZ): The main sugar substitute product is stevia sugar, with a current production capacity of 2000 tons per year
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Investment Course
Choose stocks based on financial reports
Quickly master financial season learning guidelines
When the financial season comes, company stock prices are the most likely to rise and fall, and many excellent investors will see the financial season as a good
How to view Tesla's performance in January 2025? Pay attention to these four key points.
It's earnings season for US stocks again. The performance of giant companies not only affects their own stock prices but also influences the overall trend of th
In 【2024.11】, surged more than 0.04 million times, achieving the title of stock god Buffett! How do you view Berkshire's performance?
When it comes to legendary figures in the investment world, the name of Warren Buffett, the helm of Berkshire Hathaway, is definitely unavoidable. $Berkshire Ha